Vietnam Media Landscape Report 2023-2024 published by Global PR Hub
Global PR Hub releases its newest Vietnam Media Landscape Report 2023-2024
December 12, 2023 23:30 ET | Global PR Hub
HO CHI MINH CITY, Vietnam, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The Vietnam Media Landscape Report 2023–2024 is officially released by Global PR Hub in collaboration with MGID, professionally advised...
Freestar logo.png
Freestar Welcomes Dmitri Kazanski as Vice President of Product
September 14, 2022 08:00 ET | Freestar
PHOENIX, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Freestar, the leading monetization partner for content publishers, e-commerce sites, and app developers, announced today that it has hired 22 year ad tech...
allakos.jpg
Results from Prospective Prevalence Study Indicate that Eosinophilic Gastritis and Eosinophilic Duodenitis May be Significantly Underdiagnosed
October 26, 2020 07:00 ET | Allakos Inc.
-- 45% (181/405) of symptomatic patients biopsied with chronic functional gastrointestinal symptoms met the histologic criteria for eosinophilic gastritis and/or eosinophilic duodenitis -- --...
allakos.jpg
Allakos Reports Second Quarter 2020 Financial Results and Provides Business Update
August 10, 2020 08:00 ET | Allakos Inc.
REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell-related...
allakos.jpg
Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease
March 24, 2020 16:01 ET | Allakos Inc.
-- Antolimab (AK002) reduced gastrointestinal symptoms by 64 percent in patients with mast cell gastrointestinal disease -- -- Management to host conference call and webcast today at 5:00 pm ET -- ...
allakos.jpg
Allakos Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
February 25, 2020 16:01 ET | Allakos Inc.
REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (the Company) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell...
Native Advertising Leader, MGID, Brings Video to Content Recommendation with New Widget Capabilities
August 30, 2017 09:00 ET | MGID, Inc.
SANTA MONICA, Calif., Aug. 30, 2017 (GLOBE NEWSWIRE) -- MGID, a leading provider of native advertising and marketing solutions, today announced its content recommendation widget now supports video...
El líder en Publicidad Nativa, MGID, lanza recomendación de videos de contenidos con nueva tecnología de widgets
August 30, 2017 09:00 ET | MGID, Inc.
SANTA MONICA, California, Aug. 30, 2017 (GLOBE NEWSWIRE) -- MGID, proveedor líder en publicidad nativa y soluciones de mercadeo, anunció hoy que su widget de recomendación de contenido ahora soporta...
MGID Launches Proprietary Anti-Ad Blocking Technology
June 15, 2016 08:00 ET | MGID Inc.
SANTA MONICA, CA--(Marketwired - Jun 15, 2016) - MGID Inc., a leading native performance advertising network, today announced the launch of its new anti-ad blocking technology, developed to provide...
MGID's Native Advertising Network Combats Ad Blocking
June 06, 2016 08:00 ET | MGID
SANTA MONICA, CA--(Marketwired - Jun 6, 2016) - MGID, a leading native performance advertising network, will today present its new anti-ad blocking technology at the Interactive Advertising Bureau...